Key Highlights for Executives and Innovators
- AI Breakthrough in the OR: Proprio’s Paradigm becomes the first surgical guidance platform with FDA clearance for real-time, intraoperative measurement—ushering in the era of data-driven surgery.
- Radiation-Free Navigation: Leading hospitals like Duke Health and UW Medicine adopt Paradigm to reduce radiation exposure and improve surgical decision-making.
- Scalable Clinical Impact: The platform’s live feedback and data insights aim to reduce surgical errors, revision rates, and training gaps across high-volume spine centers.
First-Ever FDA Clearance for Real-Time Intraoperative Measurement
Proprio’s Paradigm platform now holds two FDA clearances, with the latest greenlighting its capability to deliver dynamic, 3D intraoperative measurements. This is a landmark moment in digital surgery—empowering surgeons with immediate feedback on spinal alignment and anatomical changes during procedures, without relying on radiation-heavy imaging like X-rays or CT scans. This is a pivotal step toward truly AI-augmented surgical decision-making.
Major Academic Centers Signal Adoption at Scale
World-renowned institutions such as Duke Health and UW Medicine are already using Paradigm to guide spine surgeries with real-time, 3D visualization. According to Dr. Christopher Shaffrey of Duke and Dr. Rick Bransford at UW Medicine, the technology is enabling precise screw placements, trajectory guidance, and alignment assessment—all with zero intraoperative radiation. These capabilities not only improve patient outcomes but also modernize surgical education and reduce risks for operating teams.
From Guesswork to Data-Driven Precision in Surgery
Historically, surgeons relied on pre- and post-operative imaging to assess procedural success. Paradigm eliminates this delay by continuously showing live progress toward surgical goals—offering accuracy, speed, and confidence in critical decisions. This real-time visibility could dramatically reduce the number of costly and traumatic revision surgeries, especially in complex spine and neuro cases.
Unlocking an Unprecedented AI Dataset in Surgery
Beyond intraoperative use, Proprio is building a unique, multimodal dataset enriched with expert surgeon input. With each case, the system learns and evolves, creating a powerful digital archive of techniques, outcomes, and clinical insights. This data reservoir opens new pathways for clinical research, surgeon training, and next-gen robotics—all rooted in real-world expertise. Proprio’s AI is not just about automation—it’s about intelligence that learns, adapts, and transforms the standard of care.
👉 Read the official press release from Proprio here
About Proprio AI
Proprio is a Seattle-based surgical technology company transforming the future of surgery through its AI-powered guidance platform, Paradigm—the first FDA-cleared system to deliver real-time, intraoperative 3D measurements without radiation. By combining advanced computer vision, multimodal imaging, and surgeon-informed datasets, Proprio enhances surgical precision, reduces the need for revision procedures, and improves training for the next generation of clinicians. Backed by collaborations with leading institutions like Duke Health and UW Medicine, Proprio is building the most comprehensive digital surgical platform to elevate standards of care and usher in a new era of intelligent, data-driven surgery. For more information, visit www.proprio.ai
By
